Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Hall

Showing results (121-130 of 225) with videos related to

Pageof 23
Sort By:
European Urology|January 6, 2020
The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the TestisMichael Cullen, Robert Huddart, Johnathan Joffe, et al.
International Journal of Cancer|November 4, 2004
Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 yearsMartin J Slade, Anjana Singh, Brendan M Smith, et al.
European Urology|May 16, 2022
Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-yr Follow-up of the Phase 3 Randomised Controlled BC2001 TrialEmma Hall, Syed A Hussain, Nuria Porta, et al.
European Urology Oncology|May 13, 2026
Outcomes of Intermediate Risk Non-muscle-invasive Bladder Cancer Receiving Adjuvant Treatment: A Pooled Analysis of Four Randomized Controlled TrialsWei Shen Tan, Ashish M Kamat, Rebecca Lewis, et al.
The Lancet. Oncology|February 3, 2007
Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled studyRobert E Coleman, Linda M Banks, Samia I Girgis, et al.
International Journal of Radiation Oncology, Biology, Physics|August 21, 2013
Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: results of the BC2001 trial (CRUK/01/004)Robert A Huddart, Emma Hall, Syed A Hussain, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2023
Interim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation TherapyRosalyne Laura Westley, Katie Biscombe, Alex Dunlop, et al.
BJU International|April 29, 2017
Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomyRobert A Huddart, Alison Birtle, Lauren Maynard, et al.
International Journal of Radiation Oncology, Biology, Physics|June 25, 2015
Consensus Guidelines and Contouring Atlas for Pelvic Node Delineation in Prostate and Pelvic Node Intensity Modulated Radiation TherapyVictoria A Harris, John Staffurth, Olivia Naismith, et al.
Clinical Genitourinary Cancer|May 7, 2021
Fracture Risk in Men with Metastatic Prostate Cancer Treated With Radium-223Adham Hijab, Sebastian Curcean, Nina Tunariu, et al.
Pageof 23

Showing results (121-130 of 225) with videos related to

Sort By:
Pageof 23
European Urology|January 6, 2020
The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the TestisMichael Cullen, Robert Huddart, Johnathan Joffe, et al.
International Journal of Cancer|November 4, 2004
Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 yearsMartin J Slade, Anjana Singh, Brendan M Smith, et al.
European Urology|May 16, 2022
Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-yr Follow-up of the Phase 3 Randomised Controlled BC2001 TrialEmma Hall, Syed A Hussain, Nuria Porta, et al.
European Urology Oncology|May 13, 2026
Outcomes of Intermediate Risk Non-muscle-invasive Bladder Cancer Receiving Adjuvant Treatment: A Pooled Analysis of Four Randomized Controlled TrialsWei Shen Tan, Ashish M Kamat, Rebecca Lewis, et al.
The Lancet. Oncology|February 3, 2007
Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled studyRobert E Coleman, Linda M Banks, Samia I Girgis, et al.
International Journal of Radiation Oncology, Biology, Physics|August 21, 2013
Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: results of the BC2001 trial (CRUK/01/004)Robert A Huddart, Emma Hall, Syed A Hussain, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2023
Interim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation TherapyRosalyne Laura Westley, Katie Biscombe, Alex Dunlop, et al.
BJU International|April 29, 2017
Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomyRobert A Huddart, Alison Birtle, Lauren Maynard, et al.
International Journal of Radiation Oncology, Biology, Physics|June 25, 2015
Consensus Guidelines and Contouring Atlas for Pelvic Node Delineation in Prostate and Pelvic Node Intensity Modulated Radiation TherapyVictoria A Harris, John Staffurth, Olivia Naismith, et al.
Clinical Genitourinary Cancer|May 7, 2021
Fracture Risk in Men with Metastatic Prostate Cancer Treated With Radium-223Adham Hijab, Sebastian Curcean, Nina Tunariu, et al.
Pageof 23